Feds Probe Medtronic Payments to Docs
Posted by Jacob Goldstein
Medtronic pulled off the federal probe trifecta in its quarterly report, filed yesterday with the SEC. The medical device giant it had received requests for information from Congress, the SEC and the Department of Justice during the previous quarter.
The U.S. Senate Committee on Finance sent the company two letters — one asking about “financial ties between the medical device industry and practicing physicians,” another asking about the company’s decision to suspend distribution of a family of defibrillator wires. This has already been a hot topic for makers of orthopedic implants that recently disclosed details on the payments under settlements with the Justice Department.
The United States Attorney’s Office for the Eastern District of Pennsylvania asked for “documents relating to the Company’s relationship with one of its customers and any payments or things of value provided by the Company to physicians, physician groups, hospitals, medical practices or other entities relating to the purchase of the Company’s cardiac resynchronization therapy devices and cardiac stents.” (Cardiac resynchronization therapy is explained here.)
And Medtronic got a letter from the SEC “requesting information relating to any potential violations of the U.S. Foreign Corrupt Practices Act in connection with the sale of medical devices in an unspecified number of foreign countries, including Greece, Poland and Germany.” Other device makers have disclosed receiving similar letters, according to Medtronic. For good measure, the Department of Justice also wrote to Medtronic, asking that the company send along whatever info it provides the SEC.
The company said it’s cooperating with all of the requests. At Medtronic, The Probes Just Keep On Coming
December 5th, 2007 3:25 pm By Ed Silverman
One after the other. During the past three months, the medical device maker attracted more than its share of attention, as a quick read of the latest Securities and Exchange Commission filing indicates.
First, there were two requests from Chuck Grassley, who chairs the Senate Committee on Finance. On Sept. 20, he sent a letter requesting info about financial ties between the device industry and practicing physicians. On Oct. 16, he sent a letter requesting info about the Medtronic’s decision to suspend distribution of its Sprint Fidelis family of defibrillation leads. (Several orthopedic implant makers recently settled kickback charges).
Then, on Sept. 25, the SEC sent a letter requesting info relating to any potential violations of the US Foreign Corrupt Practices Act in connection with the sale of devices in an unspecified number of foreign countries, including Greece, Poland and Germany. The letter notes Medtronic is a ’significant participant’ in the medical device industry, and seeks any info concerning certain types of payments made directly or indirectly to government-employed doctors. And on Nov. 16, the company received a letter from the Department of Justice requesting any information provided to the SEC.
Finally, on or about Oct. 31, Medtronic received a letter from the US Attorney in Philadelphia requesting documents relating to Medtronic’s relationship with one of its customers and any payments or things of value provided to physicians, physician groups, hospitals, medical practices or other entities relating to the purchase of its cardiac resynchronization therapy devices and cardiac stents.
screen.width-333)this.width=screen.width-333" width=160 height=91 title="Click to view full medtronic2.jpg (160 X 91)" border=0 align=absmiddle> [标签:content1][标签:content2]
作者:admin@医学,生命科学 2011-09-08 05:15